[HTML][HTML] Antibody response after vaccination against SARS-CoV-2 in adults with hematological malignancies: a systematic review and meta-analysis

N Gagelmann, F Passamonti, C Wolschke… - …, 2022 - ncbi.nlm.nih.gov
Vaccines against SARS-CoV-2 have shown remarkable efficacy and thus constitute an
important preventive option against coronavirus disease 2019 (COVID-19), especially in …

[HTML][HTML] Antibody response after vaccination against SARS-CoV-2 in adults with hematological malignancies: a systematic review and meta-analysis

N Gagelmann, F Passamonti, C Wolschke… - …, 2022 - haematologica.org
Vaccines against SARS-CoV-2 have shown remarkable efficacy and thus constitute an
important preventive option against coronavirus disease 2019 (COVID-19), especially in …

Antibody response after vaccination against SARS-CoV-2 in adults with hematological malignancies: a systematic review and meta-analysis

N Gagelmann, F Passamonti, C Wolschke… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Vaccines against SARS-CoV-2 have shown remarkable efficacy and thus constitute an
important preventive option against coronavirus disease 2019 (COVID-19), especially in …

[PDF][PDF] Antibody response after vaccination against SARS-CoV-2 in adults with haematological malignancies: a systematic review and meta-analysis

N Gagelmann, F Passamonti, C Wolschke… - …, 2021 - academia.edu
Vaccines against SARS-CoV-2 have shown remarkable efficacy and thus constitute an
important preventive option against COVID-19, especially in fragile patients. We aimed to …

[PDF][PDF] Antibody response after vaccination against SARS-CoV-2 in adults with haematological malignancies: a systematic review and meta-analysis

N Gagelmann, F Passamonti, C Wolschke… - …, 2021 - scholar.archive.org
Vaccines against SARS-CoV-2 have shown remarkable efficacy and thus constitute an
important preventive option against COVID-19, especially in fragile patients. We aimed to …

Antibody response after vaccination against SARS-CoV-2 in adults with hematological malignancies: a systematic review and meta-analysis.

N Gagelmann, F Passamonti, C Wolschke… - …, 2022 - europepmc.org
Vaccines against SARS-CoV-2 have shown remarkable efficacy and thus constitute an
important preventive option against coronavirus disease 2019 (COVID-19), especially in …

[PDF][PDF] Antibody response after vaccination against SARS-CoV-2 in adults with hematological malignancies: a systematic review and meta-analysis

N Gagelmann, F Passamonti, C Wolschke, R Massoud… - 2022 - scienceopen.com
Antibody response after vaccination against SARS-CoV-2 in adults with hematological
malignancies: a systematic review and meta-a Page 1 Antibody response after vaccination …

[引用][C] Antibody response after vaccination against SARS-CoV-2 in adults with hematological malignancies: a systematic review and meta-analysis

N Gagelmann, F Passamonti, C Wolschke… - …, 2022 - europepmc.org
Vaccines against SARS-CoV-2 have shown remarkable efficacy and thus constitute an
important preventive option against coronavirus disease 2019 (COVID-19), especially in …

[HTML][HTML] Antibody response after vaccination against SARS-CoV-2 in adults with hematological malignancies: a systematic review and meta-analysis

N Gagelmann, F Passamonti, C Wolschke… - …, 2022 - haematologica.org
Vaccines against SARS-CoV-2 have shown remarkable efficacy and thus constitute an
important preventive option against coronavirus disease 2019 (COVID-19), especially in …